China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.550
+0.010 (0.39%)
Jun 25, 2026, 10:28 AM EDT - Market open
China SXT Pharmaceuticals Revenue
China SXT Pharmaceuticals had revenue of $626.57K in the half year ending September 30, 2025, a decrease of -33.31%. This brings the company's revenue in the last twelve months to $1.54M, down -15.42% year-over-year. In the fiscal year ending March 31, 2025, China SXT Pharmaceuticals had annual revenue of $1.74M, down -9.73%.
Revenue (ttm)
$1.54M
Revenue Growth
-15.42%
P/S Ratio
10.67
Revenue / Employee
$20,506
Employees
75
Market Cap
16.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.74M | -187.59K | -9.73% |
| Mar 31, 2024 | 1.93M | -43.18K | -2.19% |
| Mar 31, 2023 | 1.97M | -630.60K | -24.23% |
| Mar 31, 2022 | 2.60M | -2.18M | -45.53% |
| Mar 31, 2021 | 4.78M | -384.70K | -7.45% |
| Mar 31, 2020 | 5.16M | -1.85M | -26.38% |
| Mar 31, 2019 | 7.01M | -7.21K | -0.10% |
| Mar 31, 2018 | 7.02M | 2.14M | 43.79% |
| Mar 31, 2017 | 4.88M | 1.16M | 31.27% |
| Mar 31, 2016 | 3.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| cbdMD | 19.98M |
| China Pharma Holdings | 3.99M |
| TherapeuticsMD | 3.35M |
| Gelteq | 270.85K |
| Akanda | 258.08K |
SXTC News
- 3 months ago - China SXT Pharmaceuticals, Inc. Announces Share Re-classification - GlobeNewsWire
- 5 months ago - China SXT Pharmaceuticals Inc trading halted, news pending - TheFly
- 5 months ago - Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today - TipRanks
- 5 months ago - China SXT Pharmaceuticals announces 1-for-150 share consolidation - TheFly
- 5 months ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewsWire
- 5 months ago - China SXT announces initiative to apply AI tech across TCM supply chain - TheFly
- 5 months ago - Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - GlobeNewsWire
- 5 months ago - China SXT Pharmaceuticals announces $10M registered direct offering - TheFly